ICADE (ICAD.PA) Fundamental Analysis & Valuation

EPA:ICAD • FR0000035081

Current stock price

20.14 EUR
-0.12 (-0.59%)
Last:

This ICAD.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ICAD.PA Profitability Analysis

1.1 Basic Checks

  • ICAD had positive earnings in the past year.
  • ICAD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
  • In the past 5 years ICAD always reported a positive cash flow from operatings.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of ICAD (-1.29%) is worse than 80.49% of its industry peers.
  • ICAD's Return On Equity of -3.17% is on the low side compared to the rest of the industry. ICAD is outperformed by 82.93% of its industry peers.
  • ICAD has a worse Return On Invested Capital (2.68%) than 70.73% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.75%.
  • The last Return On Invested Capital (2.68%) for ICAD is above the 3 year average (2.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.29%
ROE -3.17%
ROIC 2.68%
ROA(3y)-4.9%
ROA(5y)-2.42%
ROE(3y)-11.54%
ROE(5y)-5.57%
ROIC(3y)2.1%
ROIC(5y)2.36%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • With a Operating Margin value of 19.07%, ICAD is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of ICAD has declined.
  • The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 19.07%
PM (TTM) N/A
GM N/A
OM growth 3Y-18.02%
OM growth 5Y-13.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ICAD.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICAD is destroying value.
  • The number of shares outstanding for ICAD remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ICAD has more shares outstanding
  • Compared to 1 year ago, ICAD has a worse debt to assets ratio.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.69, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
  • ICAD has a Altman-Z score of 0.69. This is in the lower half of the industry: ICAD underperforms 70.73% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that ICAD is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ICAD (0.92) is worse than 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACC0.91
WACC2.95%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.17 indicates that ICAD should not have too much problems paying its short term obligations.
  • The Current ratio of ICAD (1.17) is better than 82.93% of its industry peers.
  • ICAD has a Quick Ratio of 1.17. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ICAD has a better Quick ratio (0.91) than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.91
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ICAD.PA Growth Analysis

3.1 Past

  • ICAD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.01%.
  • ICAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.93% yearly.
  • Looking at the last year, ICAD shows a decrease in Revenue. The Revenue has decreased by -7.78% in the last year.
  • ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.13% yearly.
EPS 1Y (TTM)-6.01%
EPS 3Y-16.16%
EPS 5Y-8.93%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y-7.23%
Revenue growth 5Y0.13%
Sales Q2Q%-7.28%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.29% on average over the next years.
  • Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -0.08% on average per year.
EPS Next Y-5.17%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
EPS Next 5YN/A
Revenue Next Year-2.85%
Revenue Next 2Y-3.05%
Revenue Next 3Y-0.08%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICAD.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.78, which indicates a rather cheap valuation of ICAD.
  • Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 90.24% of the companies listed in the same industry.
  • ICAD is valuated cheaply when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 7.15, the valuation of ICAD can be described as very cheap.
  • ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 95.12% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, ICAD is valued rather cheaply.
Industry RankSector Rank
PE 6.78
Fwd PE 7.15
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • A cheap valuation may be justified as ICAD's earnings are expected to decrease with -3.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ICAD.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 9.38%, ICAD is a good candidate for dividend investing.
  • ICAD's Dividend Yield is rather good when compared to the industry average which is at 5.18. ICAD pays more dividend than 95.12% of the companies in the same industry.
  • ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 9.38%

5.2 History

  • The dividend of ICAD has a limited annual growth rate of 1.46%.
Dividend Growth(5Y)1.46%
Div Incr Years0
Div Non Decr Years0
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-265.61%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

ICAD.PA Fundamentals: All Metrics, Ratios and Statistics

ICADE

EPA:ICAD (4/13/2026, 11:29:03 AM)

20.14

-0.12 (-0.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-16
Inst Owners74.92%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.54B
Revenue(TTM)1.45B
Net Income(TTM)-123.00M
Analysts47.27
Price Target21.59 (7.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.38%
Yearly Dividend4.31
Dividend Growth(5Y)1.46%
DP-265.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.61%
PT rev (3m)-9.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.66%
EPS NY rev (3m)-11.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE 6.78
Fwd PE 7.15
P/S 1.06
P/FCF N/A
P/OCF 5.11
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)2.97
EY14.75%
EPS(NY)2.82
Fwd EY13.98%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)3.94
OCFY19.57%
SpS19.02
BVpS50.86
TBVpS50.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.3
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -3.17%
ROCE 3.77%
ROIC 2.68%
ROICexc 3.12%
ROICexgc 3.14%
OM 19.07%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.9%
ROA(5y)-2.42%
ROE(3y)-11.54%
ROE(5y)-5.57%
ROIC(3y)2.1%
ROIC(5y)2.36%
ROICexc(3y)2.52%
ROICexc(5y)2.69%
ROICexgc(3y)2.53%
ROICexgc(5y)2.7%
ROCE(3y)2.98%
ROCE(5y)3.38%
ROICexgc growth 3Y1.05%
ROICexgc growth 5Y0.61%
ROICexc growth 3Y1.05%
ROICexc growth 5Y0.6%
OM growth 3Y-18.02%
OM growth 5Y-13.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 21.07%
Interest Coverage 4.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.91
Altman-Z 0.69
F-Score6
WACC2.95%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)17.4%
Cap/Sales(5y)28.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.01%
EPS 3Y-16.16%
EPS 5Y-8.93%
EPS Q2Q%-0.66%
EPS Next Y-5.17%
EPS Next 2Y-5.65%
EPS Next 3Y-3.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.78%
Revenue growth 3Y-7.23%
Revenue growth 5Y0.13%
Sales Q2Q%-7.28%
Revenue Next Year-2.85%
Revenue Next 2Y-3.05%
Revenue Next 3Y-0.08%
Revenue Next 5YN/A
EBIT growth 1Y30.56%
EBIT growth 3Y-23.95%
EBIT growth 5Y-13.02%
EBIT Next Year-5.18%
EBIT Next 3Y-0.25%
EBIT Next 5Y-1.39%
FCF growth 1Y-103.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.01%
OCF growth 3Y-1.35%
OCF growth 5Y-14.31%

ICADE / ICAD.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status of ICADE (ICAD.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to ICADE (ICAD.PA). This can be considered as Fairly Valued.


What is the profitability of ICAD stock?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ICADE (ICAD.PA) stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 6.78 and the Price/Book (PB) ratio is 0.4.


Is the dividend of ICADE sustainable?

The dividend rating of ICADE (ICAD.PA) is 6 / 10 and the dividend payout ratio is -265.61%.